Langermann Sol has filed 3 insider transactions across 1 company since January 2024.
Most recent transaction: a grant/award of 117375 shares of NextCure, Inc. ($NXTC) on January 31, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 31, 2025 | NextCure, Inc. | $NXTC | Langermann Sol | Chief Scientific Officer | A | Employee Stock Option (Right to Buy) | 117375 | $0.00 | 117,375.0000 | 2,330,386 | 9999.99% | 5.04% |
| March 29, 2024 | NextCure, Inc. | $NXTC | Langermann Sol | Chief Scientific Officer | A | Employee Stock Option (Right to Buy) | 93900 | $0.00 | 93,900.0000 | 27,836,584 | 9999.99% | 0.34% |
| Jan. 31, 2024 | NextCure, Inc. | $NXTC | Langermann Sol | Chief Scientific Officer | A | Employee Stock Option (Right to Buy) | 117375 | $0.00 | 117,375.0000 | 27,836,584 | 9999.99% | 0.42% |